Becton Dickinson and Co. (NYSE:BDX) – Investment analysts at Jefferies Group issued their Q1 2017 EPS estimates for shares of Becton Dickinson and in a research report issued to clients and investors on Thursday. Jefferies Group analyst B. Couillard anticipates that the firm will post earnings per share of $2.09 for the quarter. Jefferies Group currently has a “Buy” rating on the stock. Jefferies Group also issued estimates for Becton Dickinson and’s Q3 2017 earnings at $2.52 EPS, Q4 2017 earnings at $2.49 EPS and FY2017 earnings at $9.50 EPS.

Becton Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, November 3rd. The company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.03. The business had revenue of $3.23 billion for the quarter, compared to analyst estimates of $3.22 billion. Becton Dickinson and had a return on equity of 24.44% and a net margin of 7.82%. Becton Dickinson and’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.94 EPS.

Earnings History and Estimates for Becton Dickinson and (NYSE:BDX)

A number of other equities research analysts also recently weighed in on the stock. Citigroup Inc. downgraded shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and dropped their price target for the company from $167.00 to $165.00 in a research report on Friday, September 23rd. Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a research report on Tuesday, August 16th. Argus reiterated a “buy” rating and issued a $185.00 price target on shares of Becton Dickinson and in a research report on Friday, October 21st. Zacks Investment Research upgraded shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, November 9th. Finally, Leerink Swann reiterated a “hold” rating on shares of Becton Dickinson and in a research report on Tuesday, August 9th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $175.39.

Becton Dickinson and (NYSE:BDX) opened at 162.80 on Monday. Becton Dickinson and has a 12-month low of $129.50 and a 12-month high of $181.76. The firm has a market cap of $34.66 billion, a P/E ratio of 36.26 and a beta of 1.04. The firm’s 50-day moving average price is $173.95 and its 200 day moving average price is $171.84.

A number of institutional investors have recently added to or reduced their stakes in BDX. Bollard Group LLC raised its position in Becton Dickinson and by 0.4% in the second quarter. Bollard Group LLC now owns 1,355 shares of the company’s stock valued at $230,000 after buying an additional 5 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Becton Dickinson and by 0.8% in the third quarter. Parkside Financial Bank & Trust now owns 624 shares of the company’s stock valued at $113,000 after buying an additional 5 shares during the last quarter. Wellington Shields & Co. LLC raised its position in Becton Dickinson and by 0.3% in the third quarter. Wellington Shields & Co. LLC now owns 2,517 shares of the company’s stock valued at $452,000 after buying an additional 8 shares during the last quarter. Coldstream Capital Management Inc. raised its position in Becton Dickinson and by 0.6% in the second quarter. Coldstream Capital Management Inc. now owns 1,495 shares of the company’s stock valued at $254,000 after buying an additional 9 shares during the last quarter. Finally, Northstar Group Inc. raised its position in Becton Dickinson and by 0.3% in the second quarter. Northstar Group Inc. now owns 2,956 shares of the company’s stock valued at $501,000 after buying an additional 10 shares during the last quarter. Institutional investors and hedge funds own 82.26% of the company’s stock.

In related news, insider Linda M. Tharby sold 11,704 shares of the business’s stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the transaction, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Stephen Sichak sold 10,352 shares of the business’s stock in a transaction on Friday, November 4th. The shares were sold at an average price of $176.10, for a total transaction of $1,822,987.20. Following the completion of the transaction, the insider now owns 26,892 shares in the company, valued at approximately $4,735,681.20. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.